W a n fibronectin levels rose significantly throughout pregnancy (P < 0.01) and at delivery maternal levels (315.6 + 21.2) significantly (p < 0.01) exceeded cord levels (137.9 + 11.9). Four to 8 weeks postpartum fibronectin levels remained at delivery levels (309.6 2 11.9) while total protein levels had returned to normal (7.8 + 0.1). No significant ethnic differences in fibronectin levels were observed during pregnancy or between postpartum lactating and nonlactating mothers. To test the hypothesis that NK cells have a role in clonal stem cell growth we performed clonal stem cell assays on normal bone marrow cells (cells obtained from 4 leukemic children in remission and off treatment for at least 6 months). Ficoll-Hypaque separated bone marrow cells (1x10~ or 2x10~) were incubated in rabbit C' alone (control) or in rabbit C' plus monoclonal antihuman NK cell antiserum HNK-1 (Leu-7) for 60 min. After one wash in alpha medium, control and antiserum-treated cells were resuspended to an identical volume and plated in 1% methylcellulose with 2 I.U. of sheep erythropoietin. Erythroid and myeloid colonies were scored after 6-7 days culture.
%INCREASE Hemophiliacs are at risk for a newly recognized disorder, acquired immunodeficiency syndrome (AIDS), consisting of opportunistic infections or unusual neoplasms, usually associated with a decreased number of T lymphocytes (T ) and an inverted T / lymphocyt~&~@Po (T /T ) . ~evgral studies of clinH T~~B B +~E~p t o m a t i c hemophiliacg hzve shown a high incidence of the immune abnormalities found in AIDS, leading to speculation that many hemophiliacs have had exposure to the AIDS agent through blood product therapy. We therefore evaluated the immune status of three groups of blood product recipients without AIDS. Pediatric participants included 8 hemophiliacs 13 to 17 years of age on Factor VIII therapy, 18 t'halassemics 9 to 17 years of age who received whole blood, and 12 sickle cell anemics (SCA) 8 to 17 years of age who received whole blood or plasma. Hemophilia s 5 had a significantly lower lymphocyte3count(median 1500 cells/mm ) than did thalassemics (6110 cells/mm ,3p<.001 by Wilcox or ranksum test (WRS)) and SCA (5461 cellslmm , p=.03 WRS), asso 5 iated with a relative y lower number of T (median 513 cells/mm vs 18p.5 cel1s/mm3 for thalassemics, !<.001 liRS, and vs 1573 cells/ mm for SCA, p=.03 WRS). The T /T was lower for hemophiliacs (median 0.9), than thalassemic! (?.7, p<.01 WRS) and SCA (2.2, p=.001 WRS). We conclude that immune abnormalities exist in this population with hemophilia. Differences may be related to lyophilized factor or to the large number of blood product donors represented by factor therapy. Renal tubular dysfunction (type I-renal tubular acidosis (RTA) renal failure concentrating defects and Fanconi Syndrome) has been described with SS, but the mechanism(s) responsible are unclear. We describe a patient with SS, type I-RTA, renal failure and a concentrating defect who delivered an 1860 gm female infant.Shortly after birth the neonate exhibited polyuria, a concentrating defect and type I RTA.Using a panel of 5 normal kidney targets, indirect immunofluorescence (IF) and immunoperoxidase (IP) analysis of serum samples obtained from the infant revealed IgG antibodies reactive with KTC antigens and TBM. Similar antibody reactivity against the target kidneys was noted in the mother's serum, but IgM>IgG. Test sera also showed reactivity with normal human salivary gland. At age 10 weeks the infant is thriving, off all medications, and has normal electrolyte values. Repeat IF and IP analysis of serum is negative for pathogenic antibodies. These studies strongly suggest that the transient renal tubular dysfunction was mediated by transplancentally transferred IgG reactive with neonatal KTCs. This thesis is supported by the disappearance of disease concident with disappearnace of pathogenic maternal IgG from the infants serum.
